____________________________________________________________________________________________________________
STADA
Working constantly to optimize and manage its costs, including through a cost-effective manufacturing footprint comprising 16 production sites across Europe and Asia, is central to STADA’ s strategy. Besides manufacturing products in its own manufacturing sites, the group also outsources production, leveraging a network of currently more than 400 contract manufacturing organizations( CMOs).
Responsible procurement
STADA’ s aim to deliver high-quality products efficiently and with high reliability is underpinned by a strong compliance foundation. Its supply chain management manages the complexity of a broad network of internal and external sites and to maintain supply in times of economic, environmental or political crisis. This incorporates crucial elements such as diversification of the production and sourcing network, a broad and flexible internal manufacturing capability,
a best-in-class external supply management guided by an integrated business-planning approach, an efficient regulatory function and a rigorous quality approach, while ensuring long-term global competitiveness in cost of sales. Furthermore, the group employs a‘ Responsible Procurement’ approach with a focus on the assessment of prioritized suppliers by the external sustainability assessment platform EcoVadis.
Due to its large product portfolio, which currently comprises approximately 800 molecules or active pharmaceutical ingredients( API) s across more than 25,000 SKUs for various dosage forms and package sizes, STADA employs a large international network of internal and external resources for pharmaceutical production. The quality and safety standards adhered to in its own manufacturing sites and the respective standards of external suppliers and CMOs fully comply with applicable legal and regulatory requirements.
manufacturing-today. com 103